MedPath

A retrospective study on the efficacy and safety of continuous subcutaneous hydromorphone titration for cancer pai

Not Applicable
Conditions
Moderate or severe, uncontrollable cancer pain.
Registration Number
JPRN-UMIN000046399
Lead Sponsor
The Tazuke Kofukai Medical Research Institute, Kitano Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
37
Inclusion Criteria

Not provided

Exclusion Criteria

None.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath